132 related articles for article (PubMed ID: 10195585)
1. Effects of vigabatrin intake on brain GABA activity as monitored by spectrally edited magnetic resonance spectroscopy and positron emission tomography.
Weber OM; Verhagen A; Duc CO; Meier D; Leenders KL; Boesiger P
Magn Reson Imaging; 1999 Apr; 17(3):417-25. PubMed ID: 10195585
[TBL] [Abstract][Full Text] [Related]
2. Vigabatrin: effects on human brain GABA levels by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff O; Rothman D; Behar K
Epilepsia; 1994; 35 Suppl 5():S29-32. PubMed ID: 8039467
[TBL] [Abstract][Full Text] [Related]
3. Acute effects of vigabatrin on brain GABA and homocarnosine in patients with complex partial seizures.
Petroff OA; Hyder F; Collins T; Mattson RH; Rothman DL
Epilepsia; 1999 Jul; 40(7):958-64. PubMed ID: 10403220
[TBL] [Abstract][Full Text] [Related]
4. Vigabatrin: effect on brain GABA levels measured by nuclear magnetic resonance spectroscopy.
Mattson RH; Petroff OA; Rothman D; Behar K
Acta Neurol Scand Suppl; 1995; 162():27-30. PubMed ID: 7495186
[TBL] [Abstract][Full Text] [Related]
5. Vigabatrin modulates benzodiazepine receptor activity in vivo: a positron emission tomography study in baboon.
Schmid L; Bottlaender M; Brouillet E; Fuseau C; Mazière M
J Pharmacol Exp Ther; 1996 Mar; 276(3):977-83. PubMed ID: 8786578
[TBL] [Abstract][Full Text] [Related]
6. Prolonged vigabatrin treatment modifies developmental changes of GABA(A)-receptor binding in young children with epilepsy.
Juhász C; Muzik O; Chugani DC; Shen C; Janisse J; Chugani HT
Epilepsia; 2001 Oct; 42(10):1320-6. PubMed ID: 11737167
[TBL] [Abstract][Full Text] [Related]
7. Human brain GABA levels rise after initiation of vigabatrin therapy but fail to rise further with increasing dose.
Petroff OA; Rothman DL; Behar KL; Mattson RH
Neurology; 1996 May; 46(5):1459-63. PubMed ID: 8628502
[TBL] [Abstract][Full Text] [Related]
8. Initial observations on effect of vigabatrin on in vivo 1H spectroscopic measurements of gamma-aminobutyric acid, glutamate, and glutamine in human brain.
Petroff OA; Rothman DL; Behar KL; Mattson RH
Epilepsia; 1995 May; 36(5):457-64. PubMed ID: 7614922
[TBL] [Abstract][Full Text] [Related]
9. Effects of vigabatrin on brain GABA+/CR signals in patients with epilepsy monitored by 1H-NMR-spectroscopy: responder characteristics.
Mueller SG; Weber OM; Duc CO; Weber B; Meier D; Russ W; Boesiger P; Wieser HG
Epilepsia; 2001 Jan; 42(1):29-40. PubMed ID: 11207782
[TBL] [Abstract][Full Text] [Related]
10. Human brain gamma-aminobutyric acid levels and seizure control following initiation of vigabatrin therapy.
Petroff OA; Behar KL; Mattson RH; Rothman DL
J Neurochem; 1996 Dec; 67(6):2399-404. PubMed ID: 8931472
[TBL] [Abstract][Full Text] [Related]
11. The rate of turnover of cortical GABA from [1-13C]glucose is reduced in rats treated with the GABA-transaminase inhibitor vigabatrin (gamma-vinyl GABA).
Manor D; Rothman DL; Mason GF; Hyder F; Petroff OA; Behar KL
Neurochem Res; 1996 Sep; 21(9):1031-41. PubMed ID: 8897466
[TBL] [Abstract][Full Text] [Related]
12. Measuring human brain GABA in vivo: effects of GABA-transaminase inhibition with vigabatrin.
Petroff OA; Rothman DL
Mol Neurobiol; 1998 Feb; 16(1):97-121. PubMed ID: 9554704
[TBL] [Abstract][Full Text] [Related]
13. The effect of vigabatrin (gamma-vinyl GABA) on cerebral blood flow and metabolism.
Spanaki MV; Siegel H; Kopylev L; Fazilat S; Dean A; Liow K; Ben-Menachem E; Gaillard WD; Theodore WH
Neurology; 1999 Oct; 53(7):1518-22. PubMed ID: 10534261
[TBL] [Abstract][Full Text] [Related]
14. Localized 1H NMR measurements of gamma-aminobutyric acid in human brain in vivo.
Rothman DL; Petroff OA; Behar KL; Mattson RH
Proc Natl Acad Sci U S A; 1993 Jun; 90(12):5662-6. PubMed ID: 8516315
[TBL] [Abstract][Full Text] [Related]
15. Brain GABA editing by localized in vivo (1)H magnetic resonance spectroscopy.
Bielicki G; Chassain C; Renou JP; Farges MC; Vasson MP; Eschalier A; Durif F
NMR Biomed; 2004 Apr; 17(2):60-8. PubMed ID: 15052553
[TBL] [Abstract][Full Text] [Related]
16. Effects of vigabatrin (gamma-vinyl GABA) on neurotransmission-related amino acids and on GABA and benzodiazepine receptor binding in rats.
Halonen T; Pitkänen A; Saano V; Riekkinen PJ
Epilepsia; 1991; 32(2):242-9. PubMed ID: 1672276
[TBL] [Abstract][Full Text] [Related]
17. Behavioral effects of vigabatrin correlated with whole brain gamma-aminobutyric acid metabolism in audiogenic sensitive rats.
Engelborghs S; Pickut BA; D'Hooge R; Wiechert P; Haegele K; De Deyn PP
Arzneimittelforschung; 1998 Jul; 48(7):713-6. PubMed ID: 9706369
[TBL] [Abstract][Full Text] [Related]
18. Effects of vigabatrin on the GABAergic system as determined by [123I]iomazenil SPECT and GABA MRS.
Verhoeff NP; Petroff OA; Hyder F; Zoghbi SS; Fujita M; Rajeevan N; Rothman DL; Seibyl JP; Mattson RH; Innis RB
Epilepsia; 1999 Oct; 40(10):1433-8. PubMed ID: 10528940
[TBL] [Abstract][Full Text] [Related]
19. Differential effects of vigabatrin, gamma-acetylenic GABA, aminooxyacetic acid, and valproate on levels of various amino acids in rat brain regions and plasma.
Löscher W; Hörstermann D
Naunyn Schmiedebergs Arch Pharmacol; 1994 Mar; 349(3):270-8. PubMed ID: 8208305
[TBL] [Abstract][Full Text] [Related]
20. Human brain GABA levels rise rapidly after initiation of vigabatrin therapy.
Petroff OA; Rothman DL; Behar KL; Collins TL; Mattson RH
Neurology; 1996 Dec; 47(6):1567-71. PubMed ID: 8960747
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
